Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maki Nishio is active.

Publication


Featured researches published by Maki Nishio.


Journal of Biomolecular NMR | 1995

High-resolution solution structure of siamycin II: Novel amphipathic character of a 21-residue peptide that inhibits HIV fusion

Keith L. Constantine; Mark S. Friedrichs; David J. Detlefsen; Maki Nishio; Mitsuaki Tsunakawa; Tamotsu Furumai; Hiroaki Ohkuma; Toshikazu Oki; Susan E. Hill; Robert E. Bruccoleri; Pin-Fang Lin; Luciano Mueller

SummaryThe 21-amino acid peptides siamycin II (BMY-29303) and siamycin I (BMY-29304), derived from Streptomyces strains AA3891 and AA6532, respectively, have been found to inhibit HIV-1 fusion and viral replication in cell culture. The primary sequence of siamycin II is CLGIGSCNDFAGCGYAIVCFW. Siamycin I differs by only one amino acid; it has a valine residue at position 4. In both peptides, disulfide bonds link Cys1 with Cys13 and Cys7 with Cys19, and the side chain of Asp9 forms an amide bond with the N-terminus. Siamycin II, when dissolved in a 50:50 mixture of DMSO and H2O, yields NOESY spectra with exceptional numbers of cross peaks for a peptide of this size. We have used 335 NOE distance constraints and 13 dihedral angle constraints to generate an ensemble of 30 siamycin II structures; these have average backbone atom and all heavy atom rmsd values to the mean coordinates of 0.24 and 0.52 Å, respectively. The peptide displays an unusual wedge-shaped structure, with one face being predominantly hydrophobic and the other being predominantly hydrophilic. Chemical shift and NOE data show that the siamycin I structure is essentially identical to siamycin II. These peptides may act by preventing oligomerization of the HIV transmembrane glycoprotein gp41, or by interfering with interactions between gp41 and the envelope glycoprotein gp120, the cell membrane or membrane-bound proteins [Frèchet, D. et al. (1994) Biochemistry, 33, 42–50]. The amphipathic nature of siamycin II and siamycin I suggests that a polar (or apolar) site on the target protein may be masked by the apolar (or polar) face of the peptide upon peptide/protein complexation.


Tetrahedron | 1999

Isolation and structure determination of TMC-151s: Novel polyketide antibiotics from Gliocladium catenulatum Gilman & Abbott TC 1280.

Jun Kohno; Maki Nishio; Masaaki Sakurai; Kimio Kawano; Hajime Hiramatsu; Noriaki Kameda; Noboru Kishi; Toyoharu Yamashita; Toru Okuda; Saburo Komatsubara

Abstract Six new antibiotics, TMC-151 A-F (2–7) have been isolated from organic extracts of the fermentation broth of Gliocladium catenulatum Gilman & Abbott TC 1280, isolated from a soil sample. Their structures including the absolute stereochemistries, were determined by extensive analyses of NMR and X-ray crystallography, and degradation studies. TMC-151s are novel polyketides containing D-mannopyranoside and D-mannitol or D-arabitol. These antibiotics showed moderate cytotoxicity to several tumor cell lines.


Tetrahedron | 1999

STRUCTURES OF TMC-120A, B AND C, NOVEL ISOQUINOLINE ALKALOIDS FROM ASPERGILLUS USTUS TC 1118

Jun Kohno; Hajime Hiramatsu; Maki Nishio; Masaaki Sakurai; Toru Okuda; Saburo Komatsubara

Abstract Three novel isoquinoline alkaloids, TMC-120A, B and C ( 1–3 ) have been isolated from a fermentation broth of Aspergillus ustus (Bain.) Thom & Church TC 1118, a fungus isolated from rhizosphere of grass. Their structures were determined through extensive spectroscopic analyses and chemical studies. TMC-120s ( 1–3 ) are found to be the first furo[3,2- h ]isoquinoline-type alkaloids isolated from natural sources.


Tetrahedron | 2001

Structure of TMC-69, a new antitumor antibiotic from Chrysosporium sp. TC 1068

Jun Kohno; Naomitsu Hirano; Kazutoshi Sugawara; Maki Nishio; Tomiki Hashiyama; Noriyuki Nakanishi; Saburo Komatsubara

Abstract A new antitumor antibiotic, TMC-69, possessing inhibitory activity against cdc25A phosphatase, has been isolated from the fermentation broth of a mitosporic fungus, Chrysosporium sp. TC 1068. This antibiotic was labile in solid state as well as in solution, and thus was converted to the more stable derivatives, diacetyl TMC-69 and hexahydro TMC-69, to elucidate the structure and to evaluate the biological activities. The planar structure of TMC-69 was determined, through the analysis of various NMR experiments of diacetyl TMC-69 and ESI-MS data of TMC-69, to be [5Z(E,E)]-1,4-dihydroxy-5-phenyl-3-[tetrahydro-3-methyl-5-(6-methyl-2,4-octadienylidene)-2H-pyran-2-yl]-2(1H)-pyridinone. Furthermore, the absolute configuration of tetrahydropyranyl moiety was determined by degradation studies of TMC-69, followed by the application of modified Moshers method.


Mycoscience | 2000

Production of TMC- 151, TMC- 154 and TMC- 171, a new class of antibiotics, is specific to ‘Gliocladium roseum’ group

Toru Okuda; Jun Kohno; Noboru Kishi; Yasuyuki Asai; Maki Nishio; Saburo Komatsubara

A novel class of fungal metabolites, TMC-151, TMC-154, and TMC-171 series compounds, was found exclusively inGliocladium catenulatum, Clonostachys rosea and closely related strains. These compounds were not detected in any other fungi examined. The production spectrum of each component was correlated to the morphology of the secondary conidiophores and the conidia. TMC-151 was limited toClonostachys rosea (formerlyG. roseum) forming navicular or reniform conidia orG. catenulatum with gray-green conidial masses, whereas TMC-154 and 171 were limited to the strains closely related toGliocladium roseum, which grew more slowly and formed more symmetrical conidia.


The Journal of Antibiotics | 2000

TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities.

Yutaka Koguchi; Jun Kohno; Maki Nishio; Kohei Takahashi; Toru Okuda; Tetsuo Ohnuki; Saburo Komatsubara


Journal of Organic Chemistry | 2000

Structures of TMC-95A-D: novel proteasome inhibitors from Apiospora montagnei sacc. TC 1093.

Jun Kohno; Yutaka Koguchi; Maki Nishio; Kazuya Nakao; Masataka Kuroda; Ryo Shimizu; and Tetsuo Ohnuki; Saburo Komatsubara


The Journal of Antibiotics | 1988

Pradimicin, a novel class of potent antifungal antibiotics.

Toshikazu Oki; Masataka Konishi; Kozo Tomatsu; Koji Tomita; Kyoichiro Saitoh; Mltsuaki Tsunakawa; Maki Nishio; Takeo Miyaki; Hiroshi Kawaguchi


The Journal of Antibiotics | 1989

CISPENTACIN, A NEW ANTIFUNGAL ANTIBIOTIC

Masataka Konishi; Maki Nishio; Kyoichiro Saitoh; Takeo Miyaki; Toshikazu Oki; Hiroshi Kawaguchi


Journal of Organic Chemistry | 1989

The structures of pradimicins A, B, and C: a novel family of antifungal antibiotics

Mitsuaki Tsunakawa; Maki Nishio; Hiroaki Ohkuma; Takashi Tsuno; Masataka Konishi; Takayuki Naito; Toshikazu Oki; Hiroshi Kawaguchi

Collaboration


Dive into the Maki Nishio's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jun Kohno

Mitsubishi Chemical Corporation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shinichi Suzuki

Mitsubishi Chemical Corporation

View shared research outputs
Researchain Logo
Decentralizing Knowledge